glp-1 lilly ad war leads to lawsuit by Novo Nordisk, claiming Eli misleads Administration Anounces Landmark GLP-1 Pricing

Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, Saieva L, Cypers H, Stampone T, Di Benedetto P, Gabrielli A, Fasano A, Elewaut D, Triolo G

This approach represents an opportunity to decelerate, stop, or reverse aging and AD by therapeutic interventions with these small molecules

The primary distinction between them lies in their active ingredients and mechanisms of action

As the method of delivery is subcutaneous injection, it may, in rare instances, cause minor injection-related side effects such as [2]: Itching at or around the injection site Swelling General discomfort However, these side effects are rare and were not reported at a rate deemed statistically significant during any phase 2 or 3 clinical trials involving PT-141